A company still losing money with shrinking sales, with elevated risk. Institutions are adding.
Facts from SEC filings, not a recommendation.
Last 12 months: $21.2M, down 26% from the 12 months before. Over 5 years, sales grew about 7.2% a year.
Price chart by TradingView.
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 44.7% to their holdings. 18 bought, 11 sold. 5 quarters of net buying in a row.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
1,000 shares at $2.18 · $2K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page